T. Rowe Price Investment Management, Inc. Procept Bio Robotics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,031,727 shares of PRCT stock, worth $78.4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,031,727
Previous 1,747,089
40.95%
Holding current value
$78.4 Million
Previous $107 Million
22.55%
% of portfolio
0.05%
Previous 0.07%
Shares
9 transactions
Others Institutions Holding PRCT
# of Institutions
271Shares Held
38.7MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$368 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$265 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$117 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$94.5 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$89.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.39B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...